Cargando…

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization

Detalles Bibliográficos
Autor principal:	Chhablani, Jay Kumar
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992170/ https://www.ncbi.nlm.nih.gov/pubmed/21120059 http://dx.doi.org/10.4103/0974-620X.71911

Ejemplares similares

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
por: Chhablani, Jay Kumar
Publicado: (2010)

Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for choroidal neovascularization associated with age-related macular degeneration in an Indian patient
por: Rishi, Pukhraj, et al.
Publicado: (2008)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma
por: Jang, Jung Hyun, et al.
Publicado: (2012)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2010)

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane
por: Shah, Nikunj, et al.
Publicado: (2008)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Kabeel, Mamdouh M, et al.
Publicado: (2008)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

Autofluorescence findings and role of anti-vascular endothelial growth factor in inflammatory choroidal neovascular membrane
por: Chhablani, Jay Kumar
Publicado: (2010)

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Pandey, Neeraj, et al.
Publicado: (2010)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
por: Milani, Paolo, et al.
Publicado: (2012)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala, Neal V, et al.
Publicado: (2014)

Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization
por: Cheema, Rizwan A., et al.
Publicado: (2011)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
por: Pece, Alfredo, et al.
Publicado: (2010)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Kubota-Taniai, Mariko, et al.
Publicado: (2011)

Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
por: Takkar, Brijesh, et al.
Publicado: (2017)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK
por: Claxton, Lindsay, et al.
Publicado: (2014)

Response to comment on: Flat irregular pigment epithelium detachment in central serous chorioretinopathy: A correlation with choroidal neovascular membrane
por: Gupta, Rajan, et al.
Publicado: (2020)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Yoshikawa, Tadanobu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1so8euci80c4aiodu5om0j7qdc